Tobii Dynavox announces Board of Directors

Tobii Dynavox
Press release

Tobii Dynavox, the global leader in assistive technology for communication, today announced its new Board of Directors. This is a key step in the process for the planned spin-off and public listing of Tobii Dynavox.

The new Board of Directors will include five members, with Åsa Hedin as Chair and Caroline Ingre, Henrik Eskilsson, Charlotta Falvin, and Carl Bandhold as members.

“I am honored to lead our Board and to take on this responsibility at such an exciting time for Tobii Dynavox,” said Åsa Hedin, Chair of the Board at Tobii Dynavox. “As the global leader in a market with profound impact on people’s lives, Tobii Dynavox has a unique potential to help and improve the lives for the over 50 million people living with communication difficulties. Together with the leadership team and the talented Tobii Dynavox staff, the Board will continue to develop and execute on our strategy to deliver life-changing and sustainable customer value as well as long-term value for our shareholders.”

The decision to prepare the spin-off of Tobii Dynavox was announced in April, and the aim is to have Tobii Dynavox listed on Nasdaq Stockholm by the end of this year. The spin-off will enhance the autonomy of Tobii Dynavox, and enable a clearer business focus and more agile organizations for both Tobii and Tobii Dynavox.

Tobii Dynavox Board member bios

Åsa Hedin, Chair. Industrial advisor to the Department of Microtechnology and Nanoscience at Chalmers AB. Chairman of the board of Artificial Solutions International AB. Board member of C-rad AB, Nolato AB, Cellavision AB, Biotage AB, Industrifonden and E. Öhman J:or Fonder AB. Previous Managing Director of Elekta Instrument AB. Board member of Tobii AB from 2015. Åsa holds an MSc in Biophysics and Bioengineering, University of Minnesota. BA in Physics, Gustavus Adolphus College.

Caroline Ingre, Board member. Caroline Ingre is a Specialist in neuromuscular diseases and Senior consultant neurology. Founder and Head of Karolinska ALS Center. Founder and Head of the national ALS registry in Sweden and also the Karolinska Treatment Center, focused on clinical trials for ALS. Board member of TRICALS and has several scientific board positions in ALS-related organizations, including Pharmaceutical companies. Caroline holds a Medical Doctor degree, Karolinska Institute. PhD in Neuroscience, Umeå University. Associate professor, Karolinska Institute.

Henrik Eskilsson, Board member. Henrik was the co-founder and CEO of Tobii from its inception in 2001. MSc in Industrial Engineering & Management, Linköping University, Sweden.

Charlotta Falvin, Board member. Charlotta has long experience from leading positions in IT and telecom, e.g. COO at Axis, CEO at Decuma and TAT. Chairman of the board at Skåne Startups. Board member at Invisio, Net Insight, Bure Equity, Boule Diagnostics, Nel ASA and Malmö based incubator Minc. Previous board member of Axis, Doro and Sinch. Board member of Tobii AB from 2018. Charlotta holds an MSc in Business Administration, Lund University.  

Carl Bandhold, Board member. Currently CFO of the publicly listed property developer JM AB. Previously CFO of the assistive technology company Permobil Group, as well as management consultant with the Boston Consulting Group and Accenture. Carl holds an MBA from INSEAD and MSc in Chemical Engineering from Chalmers University of Technology.

Documents

Contacts

Contact

Anders Lundin, Corporate Communications Director, Tobii Dynavox, phone: +46 (0)733 27 87 61, email: anders.lundin@tobii.com

Henrik Mawby, Head of Investor Relations, Tobii Group, phone: +46 (0)72 219 82 15, email: henrik.mawby@tobii.com

About Tobii

Tobii is the global leader in eye tracking. Our mission is to improve the world with technology that understands human attention and intent. Tobii operates through three business units: Tobii Dynavox makes specially designed computers that are controlled by eye movement or touch screens for use by people with special needs due to spinal cord injuries, CP, ALS or other medical conditions. Tobii Pro develops and sells eye tracking equipment and services used today by more than 3,500 companies and 2,500 research institutions, including 98 of the world’s 100 highest ranked universities. Tobii Tech supplies eye tracking technology for integration into consumer electronics and other products such as personal computers, virtual reality headsets, healthcare applications, automotive DMS and more. Tobii is headquartered in Sweden and is listed on Nasdaq Stockholm (TOBII). The group has over 1,000 employees. For more information:www.tobii.com.